- Drug screening and genome editing in human pancreatic cancer organoids identifies drug-gene interactions and candidates for off-label therapy
Christian K. Hirt et al, 2022, Cell Genomics CrossRef - Pristimerin overcomes adriamycin resistance in breast cancer cells through suppressing Akt signaling
GUI'E XIE et al, 2016, Oncology Letters CrossRef - Trifluoperazine, an Antipsychotic Drug, Effectively Reduces Drug Resistance in Cisplatin-Resistant Urothelial Carcinoma Cells via Suppressing Bcl-xL: An In Vitro and In Vivo Study
Kuan-Lin Kuo et al, 2019, International Journal of Molecular Sciences CrossRef - Identification of Emetine as a Therapeutic Agent for Pulmonary Arterial Hypertension
Mohammad Abdul Hai Siddique et al, 2019, Arteriosclerosis, Thrombosis, and Vascular Biology CrossRef - Targeting histone deacetylase and NFκB signaling as a novel therapy for Mucoepidermoid Carcinomas
Vivian P. Wagner et al, 2018, Scientific Reports CrossRef - In vitro screening of effectiveness and antiproliferative effects of potential ddit4 inhibitors for breast cancer cell lines
E. M. Zhidkova et al, 2022, Siberian journal of oncology CrossRef - Genome-wide siRNA screens identify RBBP9 function as a potential target in Fanconi anaemia-deficient head-and-neck squamous cell carcinoma
Govind Pai et al, 2023, Communications Biology CrossRef - Alkaloids as potential anticancer agent
Mayuri A. Patil et al, 2023, Recent Frontiers of Phytochemicals CrossRef - Molecular mechanisms of action and chemosensitization of tumor cells in ovarian cancer by phytochemicals: A narrative review on pre‐clinical and clinical studies
Josianne Rocha Barboza et al, 2023, Phytotherapy Research CrossRef - Overcoming adaptive resistance in mucoepidermoid carcinoma through inhibition of the IKK-β/IκBα/NFκB axis
Vivian P. Wagner et al, 2016, Oncotarget CrossRef - Identification of microR-106b as a prognostic biomarker of p53-like bladder cancers by ActMiR
Eunjee Lee et al, 2018, Oncogene CrossRef - Inhibition of the NRF2/KEAP1 Axis: A Promising Therapeutic Strategy to Alter Redox Balance of Cancer Cells
Emiliano Panieri et al, 2021, Antioxidants & Redox Signaling CrossRef - Cisplatin in combination with emetine and patulin showed dose and sequence dependent synergism against ovarian cancer
Md Nur Alam et al, 2020, Synergy CrossRef - Therapeutic targeting of the USP2-E2F4 axis inhibits autophagic machinery essential for zinc homeostasis in cancer progression
Wenjing Xiao et al, 2022, Autophagy CrossRef - Identification of a Novel Immune Landscape Signature for Predicting Prognosis and Response of Endometrial Carcinoma to Immunotherapy and Chemotherapy
Jinhui Liu et al, 2021, Frontiers in Cell and Developmental Biology CrossRef - Overexpression of miR-216b sensitizes NSCLC cells to cisplatin-induced apoptosis by targeting c-Jun
Gang Huang et al, 2017, Oncotarget CrossRef - Platinum-Based Combination Therapy: Molecular Rationale, Current Clinical Uses, and Future Perspectives
Chunqiu Yu et al, 2020, Journal of Medicinal Chemistry CrossRef - Exploring the potential mechanism of emetine against coronavirus disease 2019 combined with lung adenocarcinoma: bioinformatics and molecular simulation analyses
Kun Zhang et al, 2022, BMC Cancer CrossRef - Proadifen sensitizes resistant ovarian adenocarcinoma cells to cisplatin
Rastislav Jendželovský et al, 2016, Toxicology Letters CrossRef - Emetine Synergizes with Cisplatin to Enhance Anti-Cancer Efficacy against Lung Cancer Cells
Ti-Hui Wu et al, 2019, International Journal of Molecular Sciences CrossRef - Application of emetine in SARS-CoV-2 treatment: regulation of p38 MAPK signaling pathway for preventing emetine-induced cardiac complications
Mehdi Valipour et al, 2022, Cell Cycle CrossRef - Aberrant Bcl-x splicing in cancer: from molecular mechanism to therapeutic modulation
Zhihui Dou et al, 2021, Journal of Experimental & Clinical Cancer Research CrossRef - Reference Module-Based Analysis of Ovarian Cancer Transcriptome Identifies Important Modules and Potential Drugs
Xuedan Lai et al, 2022, Biochemical Genetics CrossRef